Close

Articles Posted in dangerous drugs

Updated:

Abbot Labs Accused of Hiding Testosterone Replacement Therapy Dangers

AndroGel is a topical hormone marketed to men experiencing complications from low levels of natural testosterone. AndroGel was heavily promoted by Abbott Laboratories and AbbVie Inc., with the companies selling the product through testimony from retired professional athletes. Abbott Laboratories and AbbVie Inc. also provided statistics and fed positive reports…

Updated:

Maine’s Relaxed Import Drug Law & Risk of Dangerous Drugs

Concerns regarding defective drugs in New England are heightened, following Maine’s recent passage of a law that allows residents there to import prescription drugs from overseas. The policy’s staunch critics include the Pharmaceutical Research and Manufacturer’s of America, the Maine Pharmacy Association and big-name drug manufacturers such as Pfizer and…

Updated:

Leukemia Drug Iclusig Expected to Resume Marketing Amid Safety Concerns

A new leukemia drug hit the market last year – and approval was promptly suspended by the U.S. Food and Drug Administration amid concerns that it caused the potential for life-threatening blood clots and a severe restriction of the blood vessels. The drug, known as Iclusig and ponatinib, has reportedly…

Updated:

Schedin v. Ortho-McNeil-Janssen Pharmaceuticals – Court Rejects Drugmaker’s Levaquin Appeal

The antibiotic Levaquin was marketed by drug manufacturer Ortho-McNeil Janssen (a subsidiary of Johnson & Johnson) as a safe way to treat many common bacterial infections, such as those of the sinuses, ears, lungs, airways, ears, skin, bones and joints. However, what a trial court ruled – and the Eighth…

Contact Us